[ET Net News Agency, 24 May 2021] Sino Biopharmaceutical Limited (01177) said for the
three months ended 31 March 2020, profit attributable to the owners of the parent was
RMB1,913.5 million, 118.5% higher than that of the same period last year.
Basic earnings per share attributable to the owners of the parent were RMB10.19 cent.
The board of the company has declared the payment of a quarterly dividend of HK2 cents per
share.
Revenue was RMB7,243 million, an increase of 16.4% over the same period last year. (KL)